(Circulation. 1997;95:1145-1156.)
© 1997 American Heart Association, Inc.
Articles |
Results of a Consecutive Series of Patients Receiving Only Antiplatelet Therapy After Optimized Stent Implantation
Comparison of Aspirin Alone Versus Combined Ticlopidine and Aspirin Therapy
Centro Cuore Columbus, Milan, Italy, and Toho University Ohashi Hospital (S.N.), Third Department of Internal Medicine, Tokyo, Japan.
Correspondence to Antonio Colombo, MD, Centro Cuore Columbus, Via M. Buonarroti 48, 20145 Milan, Italy. E-mail albire{at}chiostro.univr.it
Background Previous studies have shown that stents can be inserted in coronary arteries of patients who are subsequently treated safely with antiplatelet therapy only (ticlopidine and/or aspirin) with a low incidence of stent thrombosis, provided that stent expansion is adequate and there are no other flow-limiting lesions present. However, it is unknown whether ticlopidine combined with aspirin is superior to aspirin alone in preventing stent thrombosis.
Methods and Results From March 1993 through July 1995, 801 consecutive patients assigned to receive either aspirin therapy alone (ASA, 264 patients, 348 lesions) or a combination of ticlopidine and aspirin (TIC-ASA, 537 patients, 737 lesions) after a successful stent insertion, in most accomplished with intravascular ultrasound guidance, were evaluated retrospectively. At 1 month, there was no difference in the ASA group compared with the TIC-ASA group in the rate of any stent thrombosis (1.9% versus 1.9%; P=1), subacute stent thrombosis (1.9% versus 1.3%; P=.5), cumulative major adverse clinical events (1.9% versus 2.0%; P=1), and peripheral vascular complications (0.5% versus 0.2%; P=.3). Medication side effects that required termination of antiplatelet therapy occurred only in 1.9% of patients in the TIC-ASA group (P=.04).
Conclusions At 1-month clinical follow-up, stent thrombosis and other adverse clinical outcomes were not significantly different between the ASA and TIC-ASA groups. Medication side effects occurred only in patients treated with ticlopidine. These results provide further evidence of the safety of treatment with antiplatelet therapy only after optimal stent implantation and support the efficacy of aspirin alone in preventing stent thrombosis.
Key Words: stents • ultrasonics • platelet aggregation inhibitors • coronary disease • aspirin
This article has been cited by other articles:
 |
|
 |
|
  C.-C. Fang, Y. T. F. N. Jao, Y. Chen, and S.-P. Wang Coronary Stenting or Balloon Angioplasty for Chronic Total Coronary Occlusions: The Taiwan Experience (A Single-Center Report) Angiology, September 1, 2005; 56(5): 525 - 537. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Akpek, A. Arat, H. Morsi, R. P. Klucznick, C. M. Strother, and M. E. Mawad Self-Expandable Stent-Assisted Coiling of Wide-Necked Intracranial Aneurysms: A Single-Center Experience AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1223 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Roffi, P. Wenaweser, S. Windecker, H. Mehta, F. R. Eberli, C. Seiler, M. Fleisch, A. Garachemani, G. B. Pedrazzini, O. M. Hess, et al. Early exercise after coronary stenting is safe J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1569 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mehran, E. D. Aymong, D. T. Ashby, T. Fischell, H. Whitworth Jr, R. Siegel, W. Thomas, S. C. Wong, R. Narasimaiah, A. J. Lansky, et al. Safety of an Aspirin-Alone Regimen After Intracoronary Stenting With a Heparin-Coated Stent: Final Results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) Study Circulation, September 2, 2003; 108(9): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Wanke, A. Doerfler, B. Schoch, D. Stolke, and M. Forsting Treatment of Wide-Necked Intracranial Aneurysms with a Self-Expanding Stent System: Initial Clinical Experience AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1192 - 1199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip, D. S. Baim, K. K. L. Ho, J. J. Popma, A. J. Lansky, D. J. Cohen, J. P. Carrozza Jr, M. S. Chauhan, O. Rodriguez, and R. E. Kuntz Stent Thrombosis in the Modern Era : A Pooled Analysis of Multicenter Coronary Stent Clinical Trials Circulation, April 17, 2001; 103(15): 1967 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Cadroy, J.-P. Bossavy, C. Thalamas, L. Sagnard, K. Sakariassen, and B. Boneu Early Potent Antithrombotic Effect With Combined Aspirin and a Loading Dose of Clopidogrel on Experimental Arterial Thrombogenesis in Humans Circulation, June 20, 2000; 101(24): 2823 - 2828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Henry, F. Beverelli, P. B. Berger, M. R. Bell, D. Hasdai, D. R. Holmes Jr, S. Melby, and D. Grill Safety and Efficacy of Ticlopidine After Stent Placement • Response Circulation, January 25, 2000; 101 (3): e46 - e47. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Mishkel, F. V. Aguirre, R. W. Ligon, K. J. Rocha-Singh, C. L. Lucore, and for Prairie Cardiovascular Consultants Ltd Clopidogrel as adjunctive antiplatelet therapy during coronary stenting J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1884 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C I O BROOKES and U SIGWART Taming platelets in coronary stenting: ticlopidine out, clopidogrel in? Heart, December 1, 1999; 82(6): 651 - 652. [Full Text]
|
|
|
|
 |
|
 C. Haller and W. Kubler The disappointing results of PTCA in the uraemic patientare stents the answer? Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2582 - 2584. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip, M. B. Leon, K. K. L. Ho, P. C. Gordon, A. Giambartolomei, D. J. Diver, D. M. Lasorda, D. O. Williams, M. M. Fitzpatrick, A. Desjardin, et al. Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: Results from the STent anti-thrombotic regimen study (STARS) registry J. Am. Coll. Cardiol., September 1, 1999; 34(3): 698 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dirschinger, A. Kastrati, F.-J. Neumann, P. Boekstegers, S. Elezi, J. Mehilli, H. Schuhlen, J. Pache, E. Alt, R. Blasini, et al. Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome : A Randomized Evaluation of High-Pressure Inflation Circulation, August 31, 1999; 100(9): 918 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Leon, D. S. Baim, J. J. Popma, P. C. Gordon, D. E. Cutlip, K. K.L. Ho, A. Giambartolomei, D. J. Diver, D. M. Lasorda, D. O. Williams, et al. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting N. Engl. J. Med., December 3, 1998; 339(23): 1665 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Yoshitomi, S Kojima, T Sugi, M Yano, Y Matsumoto, and M Kuramochi Antiplatelet treatment with cilostazol after stent implantation Heart, October 1, 1998; 80(4): 393 - 396. [Abstract] [Full Text]
|
|
|
|
 |
|
 J.-P. Bossavy, C. Thalamas, L. Sagnard, A. Barret, K. Sakariassen, B. Boneu, and Y. Cadroy A Double-Blind Randomized Comparison of Combined Aspirin and Ticlopidine Therapy Versus Aspirin or Ticlopidine Alone on Experimental Arterial Thrombogenesis in Humans Blood, September 1, 1998; 92(5): 1518 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schuhlen, A. Kastrati, J. Dirschinger, J. Hausleiter, S. Elezi, A. Wehinger, J. Pache, M. Hadamitzky, and A. Schomig Intracoronary Stenting and Risk for Major Adverse Cardiac Events During the First Month Circulation, July 14, 1998; 98(2): 104 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Altman Controversies in Antithrombotic Therapy in Cardiovascular Diseases Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 11 - 24. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Vassalli and D. A Dichek Gene therapy for arterial thrombosis Cardiovasc Res, September 1, 1997; 35(3): 459 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Baim and J. P. Carrozza Jr Stent Thrombosis: Closing in on the Best Preventive Treatment Circulation, March 4, 1997; 95(5): 1098 - 1100. [Full Text]
|
|